• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Protocol rules out coronary artery disease

Article

University of Virginia cardiologists and radiologists have created a comprehensive cardiac MR exam that could help exclude coronary artery disease as the cause of newly diagnosed congestive heart failure.

University of Virginia cardiologists and radiologists have created a comprehensive cardiac MR exam that could help exclude coronary artery disease as the cause of newly diagnosed congestive heart failure.

The protocol features standard MR volume and functional analysis to quantify left ventricular size, delayed-enhancement MR imaging to uncover scarring associated with myocardial infarction, and coronary MR angiography to detect stenosis. Coronary MRA was performed with 3D, steady-state free precession, fast-suppressed, breath-hold imaging. Total exam time averaged 54 minutes.

Cardiologist Dr. Szilard Voros and colleagues at Virginia examined 14 patients who had no history of CAD before onset of CHF symptoms.

The preliminary study suggests that a comprehensive MR exam may help avoid coronary x-ray angiography for some patients. Based on evidence of delayed-enhancement and/or coronary MRA-identified lesions, six patients would have been referred for cardiac catheterization and eight would have been spared.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.